[REVISION HISTORY]

Mining and therapeutics companies reach 52-week highs

Updated 4 times since CLSTR started tracking revisions of this situation.

What changed

2026-08-18 08:16 UTC → 2026-08-18 19:58 UTC · added ~~removed~~

Several mining and therapeutics companies have reached new 52-week highs on major stock exchanges. Centerra Gold Inc. and Taseko Mines Ltd. saw share price increases on the Toronto Stock Exchange. Following quarterly earnings, financial institutions such as TD and Desjardins raised their price targets for Centerra Gold, while National Bank Financial increased its objective for Taseko Mines. Oruka Therapeutics reached a 52-week high on the NASDAQ despite a slight miss in quarterly earnings per share relative to consensus estimates. Analysts from Guggenheim and Barclays issued positive outlooks for the company. First Mining Gold Corp. has continued its upward momentum, hitting a new 52-week high of C$0.86. This performance follows an increased price target from HC Wainwright, which ~~set a new~~ raised its objective ~~of C$1.40, and recent insider buying activity in July by Richard Huang and Stephen Andrew Lines.~~ from C$1.20 to C$1.40. Despite reporting a quarterly loss of C$0.01 per share, analysts maintain a consensus ~~“Buy”~~ ‘Buy’ rating with a target price of C$1.05. Recent insider activity includes significant share purchases by Richard Huang and Stephen Andrew Lines. In recent stock activity, Cue Biopharma VP Michael Vincent Meluzio sold 5,628 shares on August 13 at an average price of $30.09. The sale, totaling approximately $169,346, was intended to cover tax withholding obligations related to equity award vesting and reduced his total position by 10.31%.

Versions

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.